| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | NEUTRAL | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.28▲ | 1.28▲ | 1.28▲ | 1.23▲ | 1.42▼ |
| MA10 | 1.30▼ | 1.29▼ | 1.30▼ | 1.27▲ | 1.43▼ |
| MA20 | 1.31▼ | 1.27▲ | 1.23▲ | 1.42▼ | 1.04▲ |
| MA50 | 1.26▲ | 1.20▲ | 1.22▲ | 1.42▼ | N/A |
| MA100 | 1.21▲ | 1.28▼ | 1.36▼ | 1.03▲ | N/A |
| MA200 | 1.30▼ | 1.50▼ | 1.60▼ | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.007▼ | -0.003▼ | 0.007▲ | -0.028▼ | 0.416▲ |
| RSI | 48.409▼ | 52.875▲ | 53.935▲ | 46.346▼ | 29.099▼ |
| STOCH | 28.205 | 36.182 | 43.235 | 30.462 | 35.518 |
| WILL %R | -61.538 | -66.667 | -61.111 | -58.549 | -73.278 |
| CCI | -54.902 | -72.077 | 2.469 | -12.370 | 2.165 |
|
Monday, August 11, 2025 05:13 AM
MND combines proprietary resveratrol-based platform and NovaSOL® Curcumin to enhance cognitive performance and support neuroprotective health Jupiter, Florida, Aug. 11, 2025 (GLOBE NEWSWIRE) -- ...
|
|
Wednesday, July 23, 2025 05:14 AM
Jupiter, Florida, July 23, 2025 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) ("Jupiter" or the "Company"), a clinical-stage pharmaceutical company developing JOTROL ™ , a ...
|
|
Thursday, July 10, 2025 06:40 AM
By Meg Flippin Benzinga DETROIT, MICHIGAN - July 10, 2025 (NEWMEDIAWIRE) - Christer Rosen, chairman & CEO of Jupiter Neurosciences Inc. (NASDAQ: JUNS), was recently a guest on Benzinga's All-Access.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 15/08/25 | 1.37 | 1.389 | 1.21 | 1.29 | 151,900 |
| 14/08/25 | 1.29 | 1.5177 | 1.16 | 1.34 | 597,296 |
| 13/08/25 | 1.08 | 1.25 | 1.08 | 1.24 | 171,200 |
| 12/08/25 | 1.16 | 1.16 | 1.05 | 1.11 | 285,400 |
| 11/08/25 | 1.25 | 1.27 | 1.11 | 1.15 | 153,600 |
| 08/08/25 | 1.25 | 1.27 | 1.17 | 1.21 | 117,491 |
| 07/08/25 | 1.32 | 1.32 | 1.19 | 1.28 | 82,917 |
| 06/08/25 | 1.38 | 1.40 | 1.14 | 1.22 | 268,300 |
| 05/08/25 | 1.52 | 1.53 | 1.33 | 1.38 | 94,779 |
| 04/08/25 | 1.40 | 1.5443 | 1.35 | 1.50 | 112,050 |
|
|
||||
|
|
||||
|
|